Peter Vadas
6Patents
4h-index
7Co-inventors
50Inventor score
Filing activity: Jul 6, 1988 → Sep 3, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6043231A | Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines | Emerging Cross-Sectional Technologies | 43 | Expired |
| US5019508A | Synovial phospholipases | Human Necessities | 36 | Expired |
| US5523297A | Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines | Human Necessities | 31 | Expired |
| US5552530A | Antibodies that specifically bind to and inhibit human synovial phospholipase A.sub.2 type A | Human Necessities | 6 | Expired |
| US8257697B2 | Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis | Physics | 0 | Active |
| US8562982B2 | Use of platelet activating factor acetylhydrolase as a biomarker for anaphylaxis | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.